Myclonic status epilepticus: Video presentation

Movement Disorders

Volumn 17, Issue 2, 2002, Pages 409-411

  Badhawar, Aman ^a   Siren, Auli ^a   Andermann, Eva ^a   Andermann, Frederick ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; ETIRACETAM; LAMOTRIGINE; NITRAZEPAM; PHENYTOIN; PIRACETAM; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

ADULT; ARTICLE; CASE REPORT; ELECTROENCEPHALOGRAPHY; ENDOCRINE DISEASE; EPILEPTIC STATE; FAMILY HISTORY; FEMALE; HAIR LOSS; HUMAN; MYOCLONUS EPILEPSY; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT COMPLIANCE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SLEEP DISORDER; SPIKE WAVE; TERATOGENICITY; TONIC CLONIC SEIZURE; TREMOR; VIDEORECORDING; WEIGHT GAIN; MULTIMODALITY CANCER THERAPY; PSYCHOLOGICAL ASPECT; PSYCHOTHERAPY; TREATMENT REFUSAL;

ADULT; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MYOCLONIC EPILEPSY, JUVENILE; PSYCHOTHERAPY; STATUS EPILEPTICUS; TREATMENT REFUSAL; VALPROIC ACID; VIDEO RECORDING;

EID: 0036489448     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.10079     Document Type: Article

References (18)

1. Grunewald RA, Chroni E, Panayiotopoulos CP. Delayed diagnosis of juvenile myoclonic epilepsy. J Neurol Neurosurg Psychiatry 1992;55:497-499.
2. Panayiotopoulos CP, Obeid T, Tahan AR. Juvenile myoclonic epilepsy: a 5-year prospective study. Epilepsia 1994;35:285-296.
3. Treiman DM. Electroclinical features of status epilepticus. J Clin Neurophysiol 1995;12:343-362.
4. Gastaut H. Classification of status epilepticus. Adv Neurol 1983; 34:15-35.
5. Roger J, Lob H, Regis H, Gastaut H. Les états de mal généralisés myocloniques. In: Gastaut H, Roger J, Lob H, editors. Les états de mal épileptiques. Paris: Masson; 1967. p 77-84.
6. Janz D. Die Epilepsien; spezielle Pathologie and Therapie. Stuttgart: Georg Thieme Verlag; 1969.
7. Grunenberg F, Helmchen H. Impulsiv-petit mal-Status und paranoide Psychose. Nervenarzt 1969;40:381-385.
8. Ohtahara S, Oka E, Yamatogi Y, Ohtsuka Y, Ishida T, Ichiba N, Ishida S, Miyake S. Non-convulsive status epilepticus in childhood. Folia Psychiatr Neurol Jpn 1979;33:345-351.
9. Jumao-as A, Brenner RP. Myoclonic status epilepticus: a clinical and electroencephalographic study. Neurology 1990;40:1199-1202.
10. Sheth RD, Gidal BE. Intravenous valproic acid for myoclonic status epilepticus. Neurology 2000;54:1201.
11. Covanis A, Gupta AK, Jeavons PM. Sodium valproate: monotherapy and polytherapy. Epilepsia 1982;23:693-720.
12. Isojarvi JI, Rattya J, Myllyla VV, Knip M, Koivunen R, Pakarinen AJ, Tekay A, Tapanainen JS. Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy. Ann Neurol 1998;43:446-451.
13. Guerrini R, Belmonte A, Parmeggiani L, Perucca E. Myoclonic status epilepticus following high-dosage lamotrigine therapy. Brain Dev 1999;21:420-424.
14. Dulac O, Plouin P, Shewmon A. Myoclonus and epilepsy in childhood: 1996 Royaumont meeting. Epilepsy Res 1998;30:91-106.
15. Obeso JA, Artieda J, Luquin MR, Vaamonde J, Martinez Lage JM. Antimyoclonic action of piracetam. Clin Neuropharmacol 1986;9: 58-64.
16. Fedi M, Reutens D, Dubeau F, Arldermann E, D'Agostino D, Andermann F. Long-term efficacy and safety of piracetam in the treatment of progressive myoclorms epilepsy. Arch Neurol 2001; 58:781-786.
17. Kasteleijn-Nolst Trenite DG, Marescaux C, Stodieck S, Edelbroek PM, Oosting J. Photosensitive epilepsy: a model to study the effects of antiepileptic drugs. Evaluation of the piracetam analogue, levetiracetam. Epilepsy Res 1996;25:225-230.
18. Leppik IE. Zonisamide. Epilepsia 1999;40(Suppl. 5):S23-29.